Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study

Hematotoxicity after chimeric antigen receptor (CAR) T-cell therapy is associated with infection and death but management remains unclear. We report results of 31 patients receiving hematopoietic stem cell boost (HSCB; 30 autologous, 1 allogeneic) for either sustained severe neutropenia of grade 4 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagelmann, Nico, Wulf, Gerald Georg, Duell, Johannes, Glass, Bertram, van Heteren, Pearl, von Tresckow, Bastian, Fischer, Monika, Penack, Olaf, Ayuk, Francis, Einsele, Herrmann, Holtick, Udo, Thomson, Julia, Dreger, Peter, Kröger, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Stimulus Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984300/
https://www.ncbi.nlm.nih.gov/pubmed/35696759
http://dx.doi.org/10.1182/bloodadvances.2022008042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984300/
https://www.ncbi.nlm.nih.gov/pubmed/35696759
http://dx.doi.org/10.1182/bloodadvances.2022008042

Ejemplares similares